Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | MAOB | P27338 | 10/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1243901 | 0.81 | CYP4F2 (0.46) | NPC1ALDH1A1RAB9AKMT2AMEN1 | |
| SCHEMBL1244654 | 0.80 | MAPT (0.52) | ALDH1A1RAB9AKMT2AMAOBSMN1; SMN2 | |
| SCHEMBL803825 | 0.77 | KMT2A (0.53) | NPC1ALDH1A1RAB9AKMT2AMEN1 | |
| SCHEMBL11309842 | 0.75 | MAOB (0.50) | NPC1ALDH1A1RAB9AKMT2AMEN1 | |
| SCHEMBL25620248 | 0.74 | MEN1 (0.71) | NPC1ALDH1A1RAB9AKMT2AMEN1 | |
| SCHEMBL1092605 | 0.73 | MAOB (0.59) | NPC1ALDH1A1RAB9AKMT2AMEN1 | |
| SCHEMBL29589944 | 0.72 | CES2 (0.74) | NPC1ALDH1A1RAB9AKMT2AMEN1 | |
| SCHEMBL52445 | 0.72 | CES2 (0.74) | NPC1ALDH1A1RAB9AKMT2AMEN1 | |
| SCHEMBL28126653 | 0.72 | CES2 (0.74) | NPC1ALDH1A1RAB9AKMT2AMEN1 | |
| SCHEMBL779767 | 0.72 | SRC (0.52) | KMT2AMEN1L3MBTL1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7879826-B2 | N-methyl-D-aspartate (NMDA) receptor antagonists, such as Diethyl 3,3'-[({2-[8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl]ethyl}phosphoryl)bis(oxy)]dibenzoate, used for treating pain in a mammals; analgesics | WYETH LLC (US) | 2011-02-01 | — | — | US | disclosed |
| EP-1797104-B1 | DERIVATIVES OF [2-(8,9-DIOXO-2,6-DIAZABICYCLO[5.2.0]NON-1(7)-EN-2-YL)ALKYL]PHOSPHONIC ACID AND METHOD OF MAKING THEM | WYETH CORP (US) | 2009-11-25 | — | — | EP | disclosed |
| US-20070244100-A1 | Derivatives of [2-(8,9-Dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic Acid and Methods of Making Them | WYETH (US) | 2007-10-18 | — | — | US | disclosed |
| US-7268123-B2 | Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them | WYETH (US) | 2007-09-11 | — | — | US | disclosed |
| US-20060079679-A1 | Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them | WYETH (US) | 2006-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060079679-A1 | Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them | HAO1, OXER1, HRH4 | NPC1 513/4885ALDH1A1 1328/4885RAB9A 1681/4885 |
| US-20070244100-A1 | Derivatives of [2-(8,9-Dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic Acid and Methods of Making Them | HAO1, OXER1, HRH4 | NPC1 513/4885ALDH1A1 1328/4885RAB9A 1681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.